NCT06379347 HOspitalized Patients and Clinical flUid Status, Assessment Using Point Of Care UltraSound
| NCT ID | NCT06379347 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Flevoziekenhuis |
| Condition | Volume Status |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-02-28 |
| Primary Completion | 2025-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2024-02-28 with a primary completion date of 2025-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Point of care ultrasound (POCUS) of the inferior vena cava (IVC) is a tool for assessing volume status through ultrasonography. Using a point of care ultrasound device, the physician can perform an ultrasound of the vena cava at the bedside. Previous research has demonstrated a correlation between right atrial pressure and the vena cava's diameter. Nonetheless, the majority of research has been conducted in critically ill populations to predict fluid responsiveness in patients with more complex hemodynamics. There is limited data available on the value of IVC ultrasound in the sub-acute setting on the regular ward for clinical decision-making regarding whether a patient is hypovolemic or hypervolemic. This study's objective is to assess the diagnostic utility of point-of-care ultrasonography of the IVC, by using a standardized methodology, performed by qualified ward physicians in a conventional nursing ward.
Eligibility Criteria
Inclusion Criteria: * Patient is over 18 years old. * Patient has a clinical indication for making a IVC ultrasound. * Patient is admitted until at least 24 hours after the first ultrasound. Exclusion Criteria: * Patients who are using vasopressors at the time of the ultrasound. * Patients who require invasive or non-invasive (optiflow, CPAP, BPAP) ventilation.
Contact & Investigator
Koen de Heer, MD PhD
PRINCIPAL INVESTIGATOR
Flevoziekenhuis
Frequently Asked Questions
Who can join the NCT06379347 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Volume Status. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06379347 currently recruiting?
Yes, NCT06379347 is actively recruiting participants. Contact the research team at psp@flevoziekenhuis.nl for enrollment information.
Where is the NCT06379347 trial being conducted?
This trial is being conducted at Almere Stad, Netherlands.
Who is sponsoring the NCT06379347 clinical trial?
NCT06379347 is sponsored by Flevoziekenhuis. The principal investigator is Koen de Heer, MD PhD at Flevoziekenhuis. The trial plans to enroll 150 participants.